Modified Gegen Qinlian Decoction Ameliorates DSS‐Induced Colitis in Mice via the Modulation of NF‐ κ B and Nrf2/HO‐1 Pathways
Open Access
- 16 January 2025
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1) , 7468297
Abstract
Background: This study aims to reveal the potential molecular mechanisms of modified Gegen Qinlian decoction (MGQD) in relieving ulcerative colitis (UC). Methods: C57BL/6J mice were used to establish experimental colitis via dextran sodium sulfate (DSS). Body weight, disease activity index (DAI), spleen weight, colon length, and histopathologic features were measured to evaluate the therapeutic effects of MGQD on mice with UC. The ELISA kits were employed to assess the concentrations of interleukin (IL)‐6, IL‐1β, tumor necrosis factor‐α (TNF‐α), glutathione (GSH), reactive oxygen species (ROS), and malondialdehyde (MDA). Western blot analyses were used to assess the levels of IκBα, p65, p‐IκBα, p‐p65, HO‐1, and Nrf2. Moreover, the protein levels of Nrf2 and p‐p65 were assessed by immunofluorescence. Results: Colitis‐related symptoms in mice were significantly alleviated by MGQD. Moreover, MGQD inhibited the levels of TNF‐α, IL‐1β, IL‐6, MDA, and ROS and increased the level of GSH in mice with UC. Mechanistically, MGQD prevented the activation of the NF‐κB pathway and concomitantly promoted the activation of the Nrf2/HO‐1 pathway. Conclusion: MGQD alleviated UC by suppressing inflammation and oxidative stress via the modulation of NF‐κB and Nrf2/HO‐1 pathways, suggesting that MGQD may be a candidate therapy for UC.Keywords
Funding Information
- Guangdong Provincial Hospital of Traditional Chinese Medicine (YN2024GZRPY030)
- National Natural Science Foundation of China (82341233)
- China Academy of Chinese Medical Sciences (CI2021B005)
This publication has 26 references indexed in Scilit:
- Ulcerative colitisThe Lancet, 2023
- Modified Gegen Qinlian decoction ameliorates DSS-induced chronic colitis in mice by restoring the intestinal mucus barrier and inhibiting the activation of γδT17 cellsPhytomedicine, 2023
- The influence of cytokines on the complex pathology of ulcerative colitisAutoimmunity Reviews, 2022
- What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented?Gastroenterology, 2022
- The Nrf2 in the pathophysiology of the intestine: Molecular mechanisms and therapeutic implications for inflammatory bowel diseasesPharmacological Research, 2021
- Targeting immune cell circuits and trafficking in inflammatory bowel diseaseNature Immunology, 2019
- Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel DiseasesTrends in Molecular Medicine, 2019
- Immunopathogenesis of IBD: current state of the artNature Reviews Gastroenterology & Hepatology, 2015
- Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2‐deficient mice upon dextran sulfate treatmentInternational Journal of Cancer, 2007
- Animal models of intestinal inflammation: ineffective communication between coalition membersSpringer Seminars in Immunopathology, 2005